Acquisition Integration And Enterprise Transformation Firm
Home-based NJ firm for life sciences acquisition integration and ERP work
On NextCompany since September 3, 2026 (42 days)
NJ area
Management consultingSoftware development & consultingTechnology & SoftwareProfessional ServicesHome-based
Business overview
This New Jersey consultancy helps pharma, medical device, and CPG clients integrate acquisitions. The practice has supported these clients for nearly two decades. Consultants implement ERP, CRM, and MES systems and lead PMO work. They advise on SAP ECC to S/4HANA migrations and GMP quality alignment.
Teams complete the work remotely from home offices or client sites. Onsite and offshore teams deliver work in North America, Europe, and Asia. The asking price is $1,500,000, with $636,800 in gross revenue and $388,745 in cash flow. The owner will stay after closing for a transition period both sides agree on.
Who is a good fit for this business
- Owner-operators who will run this home-based practice rather than hold it absentee.
- Buyers who can complete a $1,500,000 purchase without seller financing.
- Strategic acquirers in life sciences IT that want S/4HANA and acquisition integration work.
Details
- Real estate
- No real estate
Frequently Asked Questions
The firm helps pharma, medical device, and CPG clients integrate acquisitions. Consultants implement ERP, CRM, and MES systems and lead PMO work. They also advise on SAP ECC to S/4HANA migrations, hardware and software migration, and GMP quality alignment. That mix has been the practice for nearly two decades.
The practice is based in New Jersey and runs as a home-based firm. Teams work from home offices or from client sites. Onsite and offshore teams deliver projects in North America, Europe, and Asia. The sale does not include real estate, and the firm is not relocatable.
Buyers face an asking price of $1,500,000 for this consultancy. The practice produces $636,800 in gross revenue. SDE cash flow is $388,745. The seller does not offer financing, so a buyer funds the $1,500,000 price without a seller note.
The owner will stay after closing for a transition period both sides agree on. The current owner operates the practice rather than holding it absentee. A buyer should expect to run the firm after that handoff. The parties set the length of that stay together.
Growth plans center on vendor relationships and more acquisition IT integrations. S/4HANA migrations form another growth focus. The firm also aims to expand its PMO toolkit in life sciences. Those paths build on the CPG and life sciences work the practice already performs.